Yin, H.-L.; Wu, C.-C.; Lin, C.-H.; Chai, C.-Y.; Hou, M.-F.; Chang, S.-J.; Tsai, H.-P.; Hung, W.-C.; Pan, M.-R.; Luo, C.-W.
β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer. Int. J. Mol. Sci. 2016, 17, 1432.
https://doi.org/10.3390/ijms17091432
AMA Style
Yin H-L, Wu C-C, Lin C-H, Chai C-Y, Hou M-F, Chang S-J, Tsai H-P, Hung W-C, Pan M-R, Luo C-W.
β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 2016; 17(9):1432.
https://doi.org/10.3390/ijms17091432
Chicago/Turabian Style
Yin, Hsin-Ling, Chun-Chieh Wu, Chih-Hung Lin, Chee-Yin Chai, Ming-Feng Hou, Shu-Jyuan Chang, Hung-Pei Tsai, Wen-Chun Hung, Mei-Ren Pan, and Chi-Wen Luo.
2016. "β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer" International Journal of Molecular Sciences 17, no. 9: 1432.
https://doi.org/10.3390/ijms17091432
APA Style
Yin, H. -L., Wu, C. -C., Lin, C. -H., Chai, C. -Y., Hou, M. -F., Chang, S. -J., Tsai, H. -P., Hung, W. -C., Pan, M. -R., & Luo, C. -W.
(2016). β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer. International Journal of Molecular Sciences, 17(9), 1432.
https://doi.org/10.3390/ijms17091432